Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.
Press releases published on November 3, 2025
November 3, 2025
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
Indeterminate
GlobeNewswire
November 3, 2025
Neumora Therapeutics to Participate in Upcoming Conferences in November
Indeterminate
GlobeNewswire
November 3, 2025
Climb Bio to Present at Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 3, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 3, 2025
Arvinas to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 3, 2025
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
Indeterminate
GlobeNewswire
November 3, 2025
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 3, 2025
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
Indeterminate
GlobeNewswire
November 3, 2025
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment
Indeterminate
GlobeNewswire
November 3, 2025
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
Indeterminate
GlobeNewswire
November 3, 2025
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
Indeterminate
GlobeNewswire
November 3, 2025
Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser
Indeterminate
GlobeNewswire
November 3, 2025
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
Indeterminate
GlobeNewswire
November 3, 2025
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 3, 2025
Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization
Indeterminate
GlobeNewswire